2022
2022
Plural is an early-stage investment fund that backs the most ambitious founders on a mission to change the world through technology. Our aim is to have GDP-level impact on Europe, address systemic risks and reduce the opportunity gap worldwide through the companies we back.
2013
2013
HelixNano is an AI driven biotech developing next generation mRNA therapies.
2020
2021
2021
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2019 - 2022
2019 - 2022
2019 - 2022
2019 - 2022
2018 - 2022
2018 - 2022